September 2026

Regulatory Approvals

FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC

Sep 18, 2026

FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC OncLive

Regulatory Approvals

FDA Approves Finerenone for CKD Associated With Type 1 Diabetes

Sep 18, 2026

FDA Approves Finerenone for CKD Associated With Type 1 Diabetes Patient Care Online

Credit Ratings

Strong earnings offset capital pressures as Fitch affirms China Life’s ratings

Sep 18, 2026

Strong earnings offset capital pressures as Fitch affirms China Life's ratings Asia Insurance Review

Credit Ratings

Kinross Gold stock gains as S&P upgrade highlights strong balance sheet – ad-hoc

Sep 18, 2026

Kinross Gold stock gains as S&P upgrade highlights strong balance sheet ad-hoc-news.de

Credit Ratings

Moody’s upgrades outlook to ‘stable’

Sep 18, 2026

Moody’s upgrades outlook to ‘stable’ The Daily Star

Regulatory Approvals

Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer

Regulatory Approvals

FDA Approves Ryzumvi Eye Drops for Presbyopia

Regulatory Approvals

Haemonetics says FDA clears vascular closure device

Regulatory Approvals

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery